admin

Tedros Adhanom Ghebreyesus, Director General of the World Health Organization (WHO) speaks after Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases during the 148th session of the Executive Board on the coronavirus disease (COVID-19) outbreak in Geneva, Switzerland, January 21, 2021. Christopher Black | WHO | via Reuters The Covid-19
0 Comments
In January, when Michael’s daughter lost interest in eating, he knew it was time to take action. Michael, a New York City resident (he asked that his last name not be used), began noticing changes in his daughter’s mood prior to the new year. At the end of last summer, the vivacious and social 12-year-old
0 Comments
These days, the best thing an outfit can be is versatile. We’re talking lounge-at-home-and-feel-cute-running-errands-and-get-your-sweat-on kinds of versatile. A multifunctional outfit is pure gold in our books, and coordinating sets are It. With sunnier days ahead, our editors have been craving bright, mood-boosting pieces and comfortable fabrics that can take you anywhere — or nowhere —
0 Comments
A federal judge entered a permanent injunction order against dietary supplement maker Confidence USA Inc., and two of its top executives. The permanent injunction, issued Thursday by Judge Edward R. Korman of the U.S. District Court for the Eastern District of New York, bans the company and its president, Helen Chian, and general manager and
0 Comments
For patients with triple-negative breast cancer (TNBC), neoadjuvant carboplatin plus docetaxel yields the same pathologic complete response and survival rates as a standard anthracycline-based neoadjuvant regimen ― carboplatin and paclitaxel followed by doxorubicin/cyclophosphamide ― but with less toxicity, higher completion rates, and at lower cost. The results come from a phase 2 trial that involved
0 Comments
As vaccination rollouts gather pace around the world, attention is now turning to vaccines of another kind: vaccine passports. Last week, the International Air Travel Association (IATA) announced the launch of its new digital travel pass as “the way forward” in resuming quarantine-free international travel. The app, which is so far being trialed by 30
0 Comments
bardoxolone Treatment for Alport Syndrome Reata Pharmaceuticals, Inc. Submits NDA for Company’s Lead Program: Bardoxolone in Alport Syndrome PLANO, Texas, March 01, 2021 (GLOBE NEWSWIRE) — Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the “Company,” or “we”), a clinical-stage biopharmaceutical company, today announced that it has submitted a New Drug Application (“NDA”) for bardoxolone methyl (“bardoxolone”) for the treatment of
0 Comments
One of the hallmarks of chronic pain is inflammation, and scientists at the UNC School of Medicine have discovered that anti-inflammatory cells called MRC1+ macrophages are dysfunctional in an animal model of neuropathic pain. Returning these cells to their normal state could offer a route to treating debilitating pain caused by nerve damage or a
0 Comments
26 February 2021 — Positive full results from the pivotal NAVIGATOR Phase III trial showed AstraZeneca and Amgen’s tezepelumab demonstrated a statistically significant and clinically meaningful1 reduction in the annualised asthma exacerbation rate (AAER) in severe, uncontrolled asthma patients.2 The results were presented at the American Academy of Asthma Allergy & Immunology Virtual Annual Meeting.2
0 Comments
Real-time quaking-induced conversion (RT-QuIC), a test for pathological misfolded protein, detected alpha-synuclein in the cerebrospinal fluid (CSF) of patients with isolated rapid-eye-movement (REM) sleep behavior disorder (IRBD), years before clinical symptoms of Parkinson’s disease or dementia with Lewy bodies emerged. In these patients, RT-QuIC detected misfolded alpha-synuclein in CSF with both sensitivity and specificity of
0 Comments
A year into the coronavirus pandemic, it’s harder than ever to know what products to trust. The pandemic has given rise to medical and wellness markets filled with misleading claims, rushed solutions, and outright fraudsters hocking counterfeit and inadequate products.  The FDA is working to separate the wheat from the chaff, issuing Emergency Use Authorizations
0 Comments
Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. A recent decrease in the number of Americans seeking testing for COVID-19 has experts on alert. Accurate and timely testing remains critical for treating and isolating individuals with SARS-CoV-2 infection, they stress. Widespread testing also allows for tracking the spread of the virus and
0 Comments
FDA Approves Azstarys (serdexmethylphenidate and dexmethylphenidate) Capsules for the Once-Daily Treatment for ADHD CELEBRATION, Fla., March 02, 2021 (GLOBE NEWSWIRE) — KemPharm, Inc. (NASDAQ: KMPH), a specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs, today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application for
0 Comments
TARRYTOWN, N.Y., Feb. 27, 2021 /PRNewswire/ – Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced detailed results from a Phase 2 proof-of-concept trial evaluating the investigational antibody cocktail REGN1908-1909 in cat-allergic patients with mild asthma. The trial met the primary endpoint of preventing early asthma reactions (EAR, defined as a ≥20% decline in forced expiratory volume over one
0 Comments
An observational study was conducted through the Fondazione Policlinico Universitario Agostino Gemelli IRCCS (Rome, Italy) to determine if those who experienced severe COVID-19 infections developed posttraumatic stress disorder (PTSD). There were 381 participants involved in the study ranging in age from 18 to 89, which took place from April 2020 to October 2020. Approximately 80%
0 Comments